Gene · 2072
Papers3,434
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,434
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Polycarcin V induces DNA-damage response and enables the profiling of DNA-binding proteins. | Natl Sci Rev | 2022 | 36601137 | PubTator, text mining | PubMed |
| Rise of the natural red pigment 'prodigiosin' as an immunomodulator in cancer. | Cancer Cell Int | 2022 | 36577970 | PubTator, text mining | PubMed |
| Exploring biomarkers for prognosis and neoadjuvant chemosensitivity in rectal cancer: Multi-omics and ctDNA sequencing collaboration. | Front Immunol | 2022 | 36569844 | PubTator, text mining | PubMed |
| Repurposing Antimalarial Pyronaridine as a DNA Repair Inhibitor to Exploit the Full Potential of Gold-Nanoparticle-Mediated Radiation Response. | Pharmaceutics | 2022 | 36559288 | PubTator, text mining | PubMed |
| Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene Targets. | Cancers (Basel) | 2022 | 36551731 | PubTator, text mining | PubMed |
| Adverse Effects of Black Carbon (BC) Exposure during Pregnancy on Maternal and Fetal Health: A Contemporary Review. | Toxics | 2022 | 36548612 | PubTator, text mining | PubMed |
| Anticarcinogenic potentials of tea catechins. | Front Nutr | 2022 | 36545470 | PubTator, text mining | PubMed |
| FANCD2 promotes mitotic rescue from transcription-mediated replication stress in SETX-deficient cancer cells. | Commun Biol | 2022 | 36543851 | PubTator, text mining | PubMed |
| Revisiting the Anti-Cancer Toxicity of Clinically Approved Platinating Derivatives. | Int J Mol Sci | 2022 | 36499737 | PubTator, text mining | PubMed |
| DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities. | Int J Mol Sci | 2022 | 36499000 | PubTator, text mining | PubMed |
| Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma Subgroups. | Cancers (Basel) | 2022 | 36497420 | PubTator, text mining | PubMed |
| Pre-Existing and Acquired Resistance to PARP Inhibitor-Induced Synthetic Lethality. | Cancers (Basel) | 2022 | 36497275 | PubTator, text mining | PubMed |
| Biological Functions of the DNA Glycosylase NEIL3 and Its Role in Disease Progression Including Cancer. | Cancers (Basel) | 2022 | 36497204 | PubTator, text mining | PubMed |
| The XPA Protein-Life under Precise Control. | Cells | 2022 | 36496984 | PubTator, text mining | PubMed |
| NEDDylated Cullin 3 mediates the adaptive response to topoisomerase 1 inhibitors. | Sci Adv | 2022 | 36490343 | PubTator, text mining | PubMed |
| RAD18 opposes transcription-associated genome instability through FANCD2 recruitment. | PLoS Genet | 2022 | 36480547 | PubTator, text mining | PubMed |
| The remodeling of Z-DNA in the mammalian germ line. | Biochem Soc Trans | 2022 | 36454621 | PubTator, text mining | PubMed |
| A nuclease-mimetic platinum nanozyme induces concurrent DNA platination and oxidative cleavage to overcome cancer drug resistance. | Nat Commun | 2022 | 36450764 | PubTator, text mining | PubMed |
| Pathway-level mutation analysis in primary high-grade serous ovarian cancer and matched brain metastases. | Sci Rep | 2022 | 36446793 | PubTator, text mining | PubMed |
| Cell-Free DNA Sequencing Reveals Gene Variants in DNA Damage Repair Genes Associated with Prognosis of Prostate Cancer Patients. | Cells | 2022 | 36429046 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2072/papers?page=21